Table 2 Characteristics of blood pressure and MRI findings
No-HOH Episode group (n = 352) | 1 HOH Episode group (n = 214) | ≥2 HOH Episodes group (n = 97) | P value | |
---|---|---|---|---|
Characteristic of blood pressure | ||||
Clinic SBP (mm Hg) | 148.98 ± 15.96 | 150.96 ± 16.33 | 152.31 ± 16.67 | 0.130 |
Clinic DBP (mm Hg) | 77.48 ± 8.79 | 76.21 ± 9.54 | 78.29 ± 10.81 | 0.133 |
Home supine SBP (mm Hg) | 138.01 ± 15.90 | 140.22 ± 15.85 | 141.70 ± 15.98 | 0.074 |
Home supine DBP (mm Hg) | 73.16 ± 9.05 | 72.07 ± 9.70 | 74.02 ± 10.87 | 0.201 |
Home orthostatic SBP (mm Hg) | 126.03 ± 17.34 | 123.58 ± 17.16 | 117.07 ± 17.79*,† | <0.001 |
Home orthostatic DBP (mm Hg) | 67.70 ± 9.42 | 64.00 ± 9.84* | 64.77 ± 11.23* | <0.001 |
Changes in home supine-to-orthostatic SBP (mm Hg) | 11.99 ± 6.41 | 16.64 ± 6.59* | 24.63 ± 5.13*,† | <0.001 |
Changes in home supine-to-orthostatic DBP (mm Hg) | 5.47 ± 3.10 | 8.07 ± 1.39* | 9.25 ± 1.63*,† | <0.001 |
Brain magnetic resonance imaging | ||||
WMH volume (mL) | 2.23 (1.65, 3.07) | 3.05 (2.52, 3.96)* | 3.84 (3.05, 5.06)*,† | <0.001 |
WMH-to-TIV ratio (%) | 0.18 (0.13, 0.24) | 0.24 (0.19, 0.29)* | 0.28 (0.23, 0.36)*,† | <0.001 |
Prevalence of Fazekas scale ≥ 2 [n (%)] | 33 (9.4) | 40 (18.7)* | 33 (34.0)*,† | <0.001 |
Prevalence of lacunes [n (%)] | 31 (8.8) | 33 (15.4)* | 33 (34.0)*,† | <0.001 |
Number of lacunes [total counts (%)] | 92 (26.1) | 84 (39.3)* | 136 (140.2)*,† | <0.001 |
Prevalence of EVRS (n [%]) | 32 (9.1) | 37 (17.3)* | 27 (27.8)*,† | <0.001 |
Number of EVRS [total counts (%)] | 146 (41.5) | 147 (68.7)* | 134 (138.1)*,† | <0.001 |
Prevalence of microbleeds [n (%)] | 25 (7.1) | 23 (10.7) | 15 (15.5)* | 0.034 |
Number of microbleeds [total counts (%)] | 75 (21.3) | 67 (31.3) | 49 (50.5)* | 0.031 |